Quarterly report pursuant to Section 13 or 15(d)

REVENUES FROM CONTRACTS WITH CUSTOMERS - Disaggregation of net revenues (Details)

v3.23.2
REVENUES FROM CONTRACTS WITH CUSTOMERS - Disaggregation of net revenues (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues $ 16,961 $ 18,235 $ 29,126 $ 39,031
Qbrexza        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues 8,079 6,111 12,173 13,487
Accutane        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues 5,579 5,200 10,227 10,107
Amzeeq        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues 1,374 1,265 2,568 4,731
Zilxi        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues 572 555 886 1,297
Targadox        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues 664 2,756 1,457 5,390
Exelderm        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues 538 1,313 1,049 2,017
Ximino        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues $ 155 $ 1,035 $ 766 $ 2,002